{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Las Vegas",
      "state": "NV",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "70465",
      "recalling_firm": "AnazaoHealth Corporation",
      "address_1": "7465 W Sunset Rd Ste 1200",
      "address_2": "N/A",
      "postal_code": "89113-1944",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit",
      "distribution_pattern": "Nationwide",
      "recall_number": "D0384-2015",
      "product_description": "Compounded Plaquex, intravenous injection, 50 ML vial.   Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.",
      "product_quantity": "51 vials",
      "reason_for_recall": "Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.",
      "recall_initiation_date": "20150126",
      "center_classification_date": "20150209",
      "termination_date": "20150209",
      "report_date": "20150218",
      "code_info": "Lot #:  112614-1MC-82186 Exp 5/26/2015; 112614-1MC-82187 Exp 5/26/2015; 112614-1MC-82188 Exp 05/26/205 ;112614-1MC-82189 Exp 5/26/2015"
    }
  ]
}